2004
DOI: 10.1038/sj.cgt.7700720
|View full text |Cite
|
Sign up to set email alerts
|

Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir

Abstract: Tumor targeting is an important issue in cancer gene therapy. We have developed a gene transfection method, based on lightinducible photochemical internalization (PCI) of a transgene, to improve gene delivery and expression selectively in illuminated areas, for example, in tumors. In the present work, we demonstrate that PCI improved the nonviral vector polyethylenimine (PEI)-mediated transfection of a therapeutic gene, the 'suicide' gene encoding herpes simplex virus thymidine kinase (HSVtk). In U87MG gliobla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
5
2
1

Relationship

4
4

Authors

Journals

citations
Cited by 32 publications
(20 citation statements)
references
References 39 publications
1
19
0
Order By: Relevance
“…Polylysine (with reporter gene EGFP) TPPS2a, TPPS4, AlPcS2a [28][29][30]85] Polyethyleneimine (PEI) (with reporter genes eGFP, luciferase and therapeutic gene HSV-thymidine kinase) TPPS2a,AlPcS2a [29,33,79] Glucosylated PEI with p53 gene TPPS2a [34,87] Glucosylated PEI with PTEN gene TPPS2a [35] NLS-peptide/plasmid complex complexed to a dendrimer-photosensitizer conjugate Dendrimer phthalocyanine [45] Cationic lipids (with reporter eGFP)* AlPcS2a [88] Targeted Gene Delivery:…”
Section: Genes (Reporters and Therapeutic-relevant)mentioning
confidence: 99%
“…Polylysine (with reporter gene EGFP) TPPS2a, TPPS4, AlPcS2a [28][29][30]85] Polyethyleneimine (PEI) (with reporter genes eGFP, luciferase and therapeutic gene HSV-thymidine kinase) TPPS2a,AlPcS2a [29,33,79] Glucosylated PEI with p53 gene TPPS2a [34,87] Glucosylated PEI with PTEN gene TPPS2a [35] NLS-peptide/plasmid complex complexed to a dendrimer-photosensitizer conjugate Dendrimer phthalocyanine [45] Cationic lipids (with reporter eGFP)* AlPcS2a [88] Targeted Gene Delivery:…”
Section: Genes (Reporters and Therapeutic-relevant)mentioning
confidence: 99%
“…Visible light has been used not only as a potential activator of photoactive therapeutic agents (Samia et al 2003;Bakalova et al 2004) but also as a therapeutic agent itself (Hogset et al 2002;Prasmickaite et al 2004;Chen et al 2005), although it remains unclear how visible light interacts with tissue and cells. Several researchers have found that violet-blue light (380-500 nm) disrupts DNA integrity and cellular processes such as mitochondrial function and mitosis, which are probably mediated by light-induced reactive oxygen species (ROS) (Aggarwal et al 1978;Gorgidze et al 1998;Pflaum et al 1998;Lewis et al 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Selbo et al demonstrated that the use of PCI enhanced the potency of the plant toxin gelonin in inhibiting cellular protein synthesis by a factor of 300 (21). In addition, the low-molecular weight drug bleomycin (22), antigenic peptides (23), immunotoxins (24,25), peptide nucleic acids (26) and even colloidal carriers for gene delivery (27)(28)(29) have been successfully delivered into the cytosol via PCI. These agents generally are not able to reach their intracellular target site efficiently, due to lack of capability to pass cellular membranes and/or the occurrence of degradation within endocytic vesicles.…”
Section: Efficacy Studiesmentioning
confidence: 99%